Cargando…

Corrigendum: Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets

Detalles Bibliográficos
Autores principales:	Brandão-Teles, Caroline, de Almeida, Valéria, Cassoli, Juliana S., Martins-de-Souza, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465795/ https://www.ncbi.nlm.nih.gov/pubmed/31024311 http://dx.doi.org/10.3389/fphar.2019.00344

Ejemplares similares

Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets
por: Brandão-Teles, Caroline, et al.
Publicado: (2019)

Ubiquitin–proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia
por: Seabra, Gabriela, et al.
Publicado: (2020)

Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Falvella, Ana Caroline Brambilla, et al.
Publicado: (2021)

Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes
por: Cassoli, Juliana S., et al.
Publicado: (2016)

Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules
por: Cassoli, Juliana Silva, et al.
Publicado: (2015)

Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Falvella, Ana Caroline Brambilla, et al.
Publicado: (2021)

Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
por: Gouvêa-Junqueira, Danielle, et al.
Publicado: (2020)

M177. THE PROTEOME OF OLIGODENDROCYTES DIFFERENTIATED FROM NEURAL STEM CELL DERIVED FROM SCHIZOPHRENIA PATIENTS
por: Teles Rodrigues, Caroline, et al.
Publicado: (2020)

13.3 EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease
por: Calsolaro, Valeria, et al.
Publicado: (2019)

High Yield of Adult Oligodendrocyte Lineage Cells Obtained from Meningeal Biopsy
por: Dolci, Sissi, et al.
Publicado: (2017)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Distinct Gene Expression Patterns of Calcium Channels and Related Signaling Pathways Discovered in Lymphomas
por: Stanwood, Shawna R., et al.
Publicado: (2022)

Corrigendum: Copper and Cobalt Ions Released From Metal Oxide Nanoparticles Trigger Skin Sensitization
por: Kim, Sung-Hyun, et al.
Publicado: (2021)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
por: Machado-Duque, Manuel Enrique, et al.
Publicado: (2021)

F198. EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

Purinergic Receptors on Oligodendrocyte Progenitors: Promising Targets for Myelin Repair in Multiple Sclerosis?
por: Lecca, Davide, et al.
Publicado: (2021)

GABA Receptor Agonists Protect From Excitotoxic Damage Induced by AMPA in Oligodendrocytes
por: Bayón-Cordero, Laura, et al.
Publicado: (2022)

Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?
por: do Rosário Souza, Mariana, et al.
Publicado: (2022)

Editorial: Antipsychotics of New Generation: Where Are We now?
por: Lipina, Tatiana V., et al.
Publicado: (2021)

Activation of liver X receptors protects oligodendrocytes in CA3 of stress-induced mice
por: Zhu, Peilin, et al.
Publicado: (2022)

Discovering Anti-Cancer Drugs via Computational Methods
por: Cui, Wenqiang, et al.
Publicado: (2020)

Do Clinicians Need to Rethink Antipsychotic Maintenance Treatment?: Pro
por: Kane, J.
Publicado: (2022)

Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014)

Corrigendum: Self-Medication Among Pregnant Women: Prevalence and Associated Factors
por: Pereira, Gabriela, et al.
Publicado: (2021)

Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues
por: Lourenço, Tânia, et al.
Publicado: (2016)

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
por: Muguruza, Carolina, et al.
Publicado: (2016)

Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance
por: Boyda, Heidi N., et al.
Publicado: (2022)

The Synergistic Anti-Apoptosis Effects of Amniotic Epithelial Stem Cell Conditioned Medium and Ponesimod on the Oligodendrocyte Cells
por: Safaeinejad, Fahimeh, et al.
Publicado: (2021)

Corrigendum: The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis
por: Wang, Erjin, et al.
Publicado: (2020)

High-Throughput Metabolomics Method for Discovering Metabolic Biomarkers and Pathways to Reveal Effects and Molecular Mechanism of Ethanol Extract From Epimedium Against Osteoporosis
por: Zhao, Jun-feng, et al.
Publicado: (2020)

Asymmetric author-topic model for knowledge discovering of big data in toxicogenomics
por: Chung, Ming-Hua, et al.
Publicado: (2015)

Methylation Landscape: Targeting Writer or Eraser to Discover Anti-Cancer Drug
por: Zhou, Wen-min, et al.
Publicado: (2021)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

Inhibition of the reward system by antipsychotic treatment
por: Juckel, Georg
Publicado: (2016)

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
por: Rohleder, Cathrin, et al.
Publicado: (2016)

Two Novel Loci of RELN Associated With Antipsychotics Response in Chinese Han Population
por: Xu, Qingqing, et al.
Publicado: (2020)

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs
por: Li, Nana, et al.
Publicado: (2020)

Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia
por: Hulshof, Tessa A., et al.
Publicado: (2020)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bi0slt2j43p6fp2dickto64ma7